Skip to main content

Table 4 Post-operative treatments and recurrence rates in endometriale cancer: comparison between current study and literature data.

From: Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings

  Stage N patients Treatment Recurrence % Pelvic or extrapelvic + pelvic recurrence
Mundt (22) I-IV 43 Chemotherapy 67.4 % 49.3%
Smith (28) IC-IV 39 CAP/RT 38.5% 20%
Gabriele(30) III-IV 21 CAP/RT 57% 50%
Bruzzone III-IV 45 CAP/RT 40% 77.8%
Martinez I-III 132 HDWART 35% 59%
Greven IC-III 46 Chemo/RT* 22% 30%
Current study ICG3-III 23 Chemo/RT+ 21.7% None
  1. CAP/RT : Cisplatin, doxorubicin and cyclophosphamide followed by radiotherapy HDWART high-dose abdomino-pelvic irradiation ^ abdominal/pelvis and vagina recurrence
  2. Chemo/RT concomitant chemo-radiation *cisplatin days 1/28 followed after radiotherapy by cispaltin and paclitaxel
  3. +concomitant radiotherapy with paclitaxel